Clinical Trial Update: Italian Platelet Technology Assessment Study [Phase 3]

View source ↗

Summary

The Phase 3 Italian Platelet Technology Assessment Study, sponsored by Centro Nazionale Sangue, evaluating Leukemia and Lymphoma indications, has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: Centro Nazionale Sangue | Conditions: Leukemia, Lymphoma | Phase 3 | Status: TERMINATED